State Of Alaska, Department Of Revenue Vir Biotechnology, Inc. Transaction History
State Of Alaska, Department Of Revenue
- $9.35 Billion
- Q2 2025
A detailed history of State Of Alaska, Department Of Revenue transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 55,076 shares of VIR stock, worth $311,179. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,076
Previous 51,128
7.72%
Holding current value
$311,179
Previous $331,000
16.31%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding VIR
# of Institutions
257Shares Held
93.5MCall Options Held
257KPut Options Held
261K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$94.3 Million0.99% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$92.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$72.4 Million0.0% of portfolio
-
State Street Corp Boston, MA5.73MShares$32.4 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.68MShares$15.2 Million0.0% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $749M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...